BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 33081702)

  • 1. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients.
    Liu L; Liu W; Zheng Y; Jiang X; Kou G; Ding J; Wang Q; Huang Q; Ding Y; Ni W; Wu W; Tang S; Tan L; Hu Z; Xu W; Zhang Y; Zhang B; Tang Z; Zhang X; Li H; Rao Z; Jiang H; Ren X; Wang S; Zheng S
    Microbes Infect; 2020; 22(4-5):206-211. PubMed ID: 32425648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
    Candel FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García de Casasola G; Gil Prieto R; San-Román Montero J; Ortega Anselmi J; Barba Martín R; Prados Roa F; Marco Martínez J; Zapatero Gaviria A
    Rev Esp Quimioter; 2020 Aug; 33(4):258-266. PubMed ID: 32492991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays.
    Wang Q; Du Q; Guo B; Mu D; Lu X; Ma Q; Guo Y; Fang L; Zhang B; Zhang G; Guo X
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
    Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.
    Liu W; Liu L; Kou G; Zheng Y; Ding Y; Ni W; Wang Q; Tan L; Wu W; Tang S; Xiong Z; Zheng S
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
    Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes of throat swabs RNA and serum antibodies for SARS-CoV-2 and their diagnostic performances in patients with COVID-19.
    Qiu X; Xiang Y; Sun J; Wang X; Chen G; Xu X; Liao S; Yang N; Li S; Yang G; Tang Y; Fan J; Xie W; Hu H; Li Y; Zheng F
    Emerg Microbes Infect; 2020 Dec; 9(1):1974-1983. PubMed ID: 32787527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
    Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
    J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
    Shen L; Wang C; Zhao J; Tang X; Shen Y; Lu M; Ding Z; Huang C; Zhang J; Li S; Lan J; Wong G; Zhu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1096-1101. PubMed ID: 32476607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.